|
Volumn 13, Issue 3, 2009, Pages 227-230
|
Reducing the cost of headache medication
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALMOTRIPTAN;
ELETRIPTAN;
FROVATRIPTAN;
GENERIC DRUG;
IMIGRAN SPRINT;
NARAGRAN;
NARATRIPTAN;
NON PRESCRIPTION DRUG;
RIZATRIPTAN;
SUMATRIPTAN;
SUMATRIPTAN SUCCINATE;
TRIPTAN DERIVATIVE;
UNCLASSIFIED DRUG;
ZOLMITRIPTAN;
CONTRACT;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG DELIVERY SYSTEM;
DRUG FORMULATION;
DRUG LEGISLATION;
DRUG RELEASE;
HEADACHE;
HUMAN;
LICENSING;
MIGRAINE;
PAIN;
PATENT;
PATIENT COMPLIANCE;
REVIEW;
ANIMALS;
COST SAVINGS;
DRUGS, GENERIC;
HEADACHE;
HUMANS;
MIGRAINE DISORDERS;
NONPRESCRIPTION DRUGS;
TRYPTAMINES;
|
EID: 65649154518
PISSN: 15313433
EISSN: None
Source Type: Journal
DOI: 10.1007/s11916-009-0038-5 Document Type: Review |
Times cited : (5)
|
References (7)
|